Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration

Journal of Surgical Research

Volumn 187, Issue 2, 2014, Pages 660-666

  Saidi, Reza F ^a   Rajeshkumar, Barur ^b   Shariftabrizi, Ahmad ^b   Dresser, Karen ^b   Walter, Otto ^b  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Acute liver failure; Complement inhibition; Complement system; Liver ischemia reperfusion injury; Regeneration

Indexed keywords

ALANINE AMINOTRANSFERASE; BROXURIDINE; CARBON TETRACHLORIDE; COMPLEMENT COMPONENT C1S INHIBITOR; CYCLINE; INTERLEUKIN 6;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HISTOPATHOLOGY; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER ISCHEMIA REPERFUSION INJURY; LIVER PROTECTION; LIVER REGENERATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; STAINING; SURVIVAL;

ACUTE LIVER FAILURE; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; LIVER ISCHEMIA-REPERFUSION INJURY; REGENERATION;

ANIMALS; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C3; HEPATECTOMY; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; LIVER TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4;

EID: 84900564230     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.09.009     Document Type: Article

References (29)

1. R.F. Saidi Current status of liver transplantation Arch Iran Med 15 2012 Dec 772
2. G. Horstick, O. Berg, and A. Heimann et al. Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects Circulation 104 2001 3125
3. J. Fu, G. Lin, and Z. Wu et al. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury Biochem Biophys Res Commun 349 2006 504
4. R.F. Saidi, J. Chang, and S. Verb et al. Effect of methylprednisolone on warm ischemia-reperfusion injury in the liver Am J Surg 193 2007 345
5. L.A. Hebert, F.G. Cosio, and D.J. Birmingham The role of the complement system in renal injury Seminars Nephrol 12 1992 408
6. B.H. Heijnen, I.H. Straatsburg, N.D. Padilla, G.J. Van Mierlo, C.E. Hack, and T.M. Van Gulik Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model Clin Exp Immunol 143 2006 15
7. R.F. Saidi, J. Chang, S. Brooks, I. Nalbantoglu, V. Adsay, and M.J. Jacobs Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat Transplant Proc 39 2007 3010
8. T.G. Lehmann, M. Heger, S. Munch, M. Kirschfink, and E. Klar In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver Transpl Int 13 Suppl. 1 2000 S547
9. R.K. Chan, S.I. Ibrahim, N. Verna, M. Carroll, F.D. Moore Jr., and H.B. Hechtman Ischaemia-reperfusion is an event triggered by immune complexes and complement Br J Surg 90 2003 1470
10. I.H. Straatsburg, M.A. Boermeester, and G.J. Wolbink et al. Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy J Hepatol 32 2000 783
11. A. Meyer zu Vilsendorf, C. Link, A. Jorns, E. Nagel, and J. Kohl Preconditioning with the prostacyclin analog epoprostenol and cobra venom factor prevents reperfusion injury and hyperacute rejection in discordant liver xenotransplantation Xenotransplantation 8 2001 41
12. L. Bergamaschini, G. Gobbo, and S. Gatti et al. Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver Clin Exp Immunol 126 2001 412
13. A. Aderem, and D.M. Underhill Mechanisms of phagocytosis in macrophages Annu Rev Immunol 17 1999 593
14. H. Jaeschke, A. Farhood, A.P. Bautista, Z. Spolarics, and J.J. Spitzer Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia Am J Physiol 264 1993 G801
15. A. Tokuka, A. Tanaka, and T. Kitai et al. Interrelationship of oxygen supply by hepatic artery and portal vein: rapid analysis of ischemia-reflow- induced changes in hepatic oxygenation in experimental and clinical subjects by tissue near-infrared spectroscopy Eur Surg Res 26 1994 342
16. H. Wakabayashi, A. Miyauchi, Y. Karasawa, I. Hamamoto, T. Maeba, and S. Tanaka Effect of warm ischemia and reperfusion injury on inducing major histocompatibility complex antigens on hepatocytes and nonparenchymal cells in the rat liver Transplant Proc 25 1993 3205
17. L.G. Thijs, C.E. Hack, and R.J. Strack Van Schijndel et al. Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects J Immunol 144 1990 2419
18. R.D. Rossen, J.L. Swain, L.H. Michael, S. Weakly, E. Giannini, and M.L. Entman Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extramyocardial mechanism of ischemic injury Circulation Res 57 1985 119
19. R.D. Rossen, L.H. Michael, and A. Kagiyama et al. Mechanism of complement activation following coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo Circulation Res 62 1988 572
20. W. Vogt, and D. Hesse Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison Immunobiology 184 1992 384
21. W. Vogt, B.Z.I. von Damerau, R. Nolte, and D. Brunahl Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5 Mol Immunol 26 1989 1133
22. S. Suzuki, S. Nakamura, and T. Koizumi et al. The beneficial effect of a prostaglandin I2 analog on ischemic rat liver Transplantation 52 1991 979
23. C. Caliezi, W.A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C.E. Hack C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema Pharmacol Rev 52 2000 91
24. A.E. Davis 3rd, P. Mejia, and F. Lu Biological activities of C1 inhibitor Mol Immunol 45 2008 4057
25. E. Seki, and D.A. Brenner Toll-like receptors and adaptor molecules in liver disease: update Hepatology 48 2008 322
26. G.K. Michalopoulos, and M.C. DeFrances Liver regeneration Science 276 1997 60
27. J.T. Guo, H. Zhou, and C. Liu et al. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections J Virol 74 2000 1495
28. H.L. Schieferdecker, G. Schlaf, M. Koleva, O. Gotze, and K. Jungermann Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6 J Immunol 164 2000 5453
29. D. Mastellos, J.C. Papadimitriou, S. Franchini, P.A. Tsonis, and J.D. Lambris A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration J Immunol 166 2001 2479